Managing HER2-Positive Gastric/GEJ Cancers: New and Emerging HER2-Targeted Therapies
Managing HER2-Positive Gastric/GEJ Cancers: New and Emerging HER2-Targeted Therapies is organized by Projects In Knowledge Inc. (PIK).
Release Date: Mar 24, 2023
Termination Date: Mar 23, 2024
Activity Goal:
The goal of this program is to provide the most current clinical information and practical management strategies on the complex challenges in gastroesophageal cancer management as seen in clinical practice, address clinical questions in a conversational style using @sk ChatBot technology, and provide complementary education interventions in an interactive and easily digestible on-demand video, live Q&A, and expert cases.
Learning Objective(s):
• Recognize the role of novel antibody-drug conjugates in treating patients with human epidermal growth factor receptor 2-positive (HER2+) gastric cancer.
• Develop optimal treatment plans for patients with HER2+ gastric cancer in the first- and later-line settings by utilizing new and emerging therapies.
Additional details will be posted as soon as information is available.